TechCrunch
JULY 20, 2021
In 2006, Alonge was a victim of fake pharmaceuticals and almost died after taking medicine that contained lethal levels of diazepam. Its proprietary technology, RxScanner, is a handheld authenticator designed for patients to verify their drugs. “ In terms of pharmaceutical e-commerce, yes that’s a different ballgame.
CIO
MARCH 25, 2024
Cultivating visibility matters for a few reasons,” says Kathryn Guarini, a former IBM CIO and now a board member at Regeneron Pharmaceuticals. Kathryn Guarini, board member, Regeneron Pharmaceuticals, and former IBM CIO Guarini “You want to be the one considered for opportunities to have an impact,” she says.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CIO
AUGUST 21, 2023
He started out as a scientist, working his way up the research and development ranks in the pharmaceutical industry, an experience steeped in curiosity that has helped shape his emphasis on continuous learning to this day.
AWS Machine Learning - AI
FEBRUARY 6, 2024
Bringing innovative new pharmaceuticals drugs to market is a long and stringent process. Because of the sensitive nature of the data and effort involved, pharmaceutical companies need a higher level of control, security, and auditability. This post is co-written with Ilan Geller, Shuyu Yang and Richa Gupta from Accenture.
TechCrunch
OCTOBER 19, 2021
The chemical industry is not considered a sexy one, but it supports many other sectors that we all depend on, such as the manufacturing of everyday consumer products, pharmaceuticals and agriculture. (I should know, I covered the petrochemical industry in the late 1990s).
CIO
JANUARY 17, 2024
The late Richard Sykes, CIO of pharmaceuticals giant ICI in the 1990s and later a columnist for CIO magazine, famously scripted starkly different scenarios of the future of ICI for board members early in his IT role. Miguel Traquina, CIO of biometric authentication company iProov, agrees. Why tell stories?
Capgemini
SEPTEMBER 1, 2020
In monetary terms, the OECD has deduced that the counterfeit pharmaceutical industry is worth $200 billion annually. Drug counterfeiting both endangers patients and negatively impacts pharmaceutical companies by increasing costs and compromising brand integrity. They kill hundreds of thousands of people globally each year.
Expert insights. Personalized for you.
261 
Let's personalize your content